Why is Jenburkt Pharma falling/rising?

As of 03-Sep, Jenburkt Pharmaceuticals Ltd. is experiencing a rise in its stock price, currently at 1,187.95, reflecting an increase of 33.05 or 2.86%. The stock has been gaining for the last four days, with a total return of 8.99% during this period. It outperformed its sector by 1.62% today, reaching an intraday high of Rs 1190, although it also touched a low of Rs 1122.1. Despite this positive movement, there has been a decline in investor participation, with delivery volume falling by 27.09% against the five-day average. The stock's performance over the past week shows a gain of 6.17%, while its year-to-date return is down by 2.20%.
In the broader market context, the Sensex has shown a slight decline of 0.27% over the past week, contrasting with Jenburkt's strong performance. While the stock has outperformed the benchmark in the short term, its one-month return is down by 7.09%, indicating some volatility. Over the longer term, Jenburkt has significantly outperformed the Sensex, with a three-year return of 100.90% compared to the benchmark's 37.01%. This suggests that while the stock is currently experiencing a positive trend, there are underlying challenges reflected in its recent performance metrics and declining investor engagement.